AU5918100A - Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 - Google Patents

Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2

Info

Publication number
AU5918100A
AU5918100A AU59181/00A AU5918100A AU5918100A AU 5918100 A AU5918100 A AU 5918100A AU 59181/00 A AU59181/00 A AU 59181/00A AU 5918100 A AU5918100 A AU 5918100A AU 5918100 A AU5918100 A AU 5918100A
Authority
AU
Australia
Prior art keywords
orf2
production
respiratory syncytial
syncytial virus
virus vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59181/00A
Inventor
Alison Bermingham
Peter L. Collins
Brian R. Murphy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU5918100A publication Critical patent/AU5918100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18561—Methods of inactivation or attenuation
AU59181/00A 1999-07-09 2000-07-07 Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 Abandoned AU5918100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14309799P 1999-07-09 1999-07-09
US60/143097 1999-07-09
PCT/US2000/018534 WO2001004321A1 (en) 1999-07-09 2000-07-07 Production of attenuated respiratory syncytial virus vaccines involving modification of m2 orf2

Publications (1)

Publication Number Publication Date
AU5918100A true AU5918100A (en) 2001-01-30

Family

ID=22502593

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59181/00A Abandoned AU5918100A (en) 1999-07-09 2000-07-07 Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2

Country Status (2)

Country Link
AU (1) AU5918100A (en)
WO (1) WO2001004321A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7485440B2 (en) 1995-09-27 2009-02-03 The United States Of America As Represented By The Department Of Health And Human Services Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
US6699476B1 (en) 1996-07-15 2004-03-02 Peter L. Collins Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
EP0912724B1 (en) 1996-07-15 2009-12-09 The Government of The United States of America, as represented by The Department of Health and Human Services Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
US7951383B2 (en) 1997-05-23 2011-05-31 The United States Of America As Represented By The Department Of Health And Human Services Attenuated parainfluenza virus (PIV) vaccines
US7201907B1 (en) 1997-05-23 2007-04-10 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines
US7632508B2 (en) 1997-05-23 2009-12-15 The United States Of America Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
US20030082209A1 (en) 2000-07-05 2003-05-01 Skiadopoulos Mario H. Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
US7662397B2 (en) 1997-07-15 2010-02-16 The United States Of America As Represented By The Department Of Health And Human Services Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
US20040005542A1 (en) 2001-06-22 2004-01-08 Krempl Christine D Respiratory syncytial virus vaccines expressing protective antigens from promotor- proximal genes
CN101260386A (en) 1999-07-09 2008-09-10 美国政府健康及人类服务部 Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
DE60129860T2 (en) * 2000-11-28 2008-04-24 MedImmune Vaccines, Inc., Mountain View RECOMBINANT RSV VIRUS EXPRESSION SYSTEMS AND VACCINATES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030054505A1 (en) * 1997-09-26 2003-03-20 Hong Jin Recombinant rsv expression systems and vaccines
JP2002541785A (en) * 1999-04-13 2002-12-10 アメリカ合衆国 Production of an attenuated chimeric respiratory rash virus vaccine from cloned nucleotide sequences

Also Published As

Publication number Publication date
WO2001004321A1 (en) 2001-01-18

Similar Documents

Publication Publication Date Title
PL352378A1 (en) Replication inhibitors of syncytial respiratory virus
AU2001263443A1 (en) F-protein epitope-based vaccine for respiratory syncytial virus infection
EG24026A (en) Respiratory syncytial virus replication inhibitors
HK1045998B (en) Respiratory syncytial virus replication inhibitors
HK1070358A1 (en) Process for the preparation of 7-substituted-3-qu inoline and 3-quinol-4-one carbonitriles.
AU4714601A (en) Respiratory nasal filter
AU5918100A (en) Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
AU2002242935A1 (en) A process for the preparation of a non-toxic anthrax vaccine
AU2002225509A1 (en) Production and of viruses, viral isolates and vaccines
AU2002354009A1 (en) Process for the preparation of secondary and tertiary amino-functional silanes, iminoorganosilanes and/or imidoorganosilanes
AU2001278337A1 (en) Respiratory syncytial virus vaccine
GB0227114D0 (en) Preparation of triethyl phostate
HU0000531D0 (en) Method for the correction of deuteranopia, filter used by the method and procedure for the production of the filter
AU1039601A (en) Medicaments for treatment of respiratory syncytial virus infections
AU2003269804A1 (en) Method of using prostacyclin to treat respiratory syncytial virus infections
AU2002337601A1 (en) Process for the preparation of simvastatin
AU2001256675A1 (en) Method of preparing virus vector
AU2001269640A1 (en) Vaccine against the influenza virus and method for producing said virus vaccine
AU2002236065A1 (en) Papillomavirus vaccines
AU4957800A (en) Vaccine against isa virus
AU6964001A (en) Vaccine against the influenza virus and method for producing said virus vaccine
AU4994800A (en) Plant-derived antigens against respiratory syncytial virus
GB0114107D0 (en) Respiratory syncytial virus
AU2002223398A1 (en) A vaccine for influenza virus and its preparation
AU2002222316A1 (en) Process for the preparation of zafirlukast

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase